Table 3 The top ten funding agencies that published the most randomized clinical trials (RCTs) involving insulin resistance between 2003 and 2022
Ranking | Funding agencies | Country | No. of documents | %a |
|---|---|---|---|---|
1st | National Institutes of Health | USA | 88 | 8.17 |
2nd | National Institute of Diabetes and Digestive and Kidney Diseases | USA | 86 | 7.99 |
3rd | National Center for Research Resources | USA | 63 | 5.85 |
4th | National Heart, Lung, and Blood Institute | USA | 45 | 4.18 |
5th | National Center for Advancing Translational Sciences | USA | 38 | 3.53 |
6th | National Institute on Aging | USA | 32 | 2.97 |
7th | National Natural Science Foundation of China | China | 26 | 2.41 |
8th | Medical Research Council | UK | 22 | 2.04 |
9th | Eunice Kennedy Shriver National Institute of Child Health and Human Development | USA | 21 | 1.95 |
10th | National Health and Medical Research Council | Australia | 15 | 1.39 |
10th | Novo Nordisk | Denmark | 15 | 1.39 |